AstraZeneca Pharmaceuticals LP

Wilmington, Delaware 19850-5437

0 studies enrolling now · 3 studies all time

What they study most

Fallopian Tube Cancer, Lung Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

Studies at this site

• ZD 1839 Plus Combination Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer — Status unconfirmed
• ZD 1839 Plus Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer — Status unconfirmed
• ZD9331 With or Without Topotecan in Treating Patients With Refractory or Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer — Completed